DOI QR코드

DOI QR Code

해수 분리 세균 Bacillus sp. DH-9의 항균활성

Antibacterial Activity of Bacillus sp. DH-9 Isolated from Sea Water

  • 김영만 (동의대학교 블루바이오 소재개발 센터) ;
  • 김도균 (동의대학교 생명응용학과) ;
  • 김남희 (동의대학교 생명응용학과) ;
  • 변태환 (동의대학교 생명응용학과) ;
  • 김아라 (동의대학교 생명응용학회) ;
  • 이은우 (동의대학교 생명응용학과) ;
  • 권현주 (동의대학교 생명응용학과) ;
  • 김병우 (동의대학교 생명응용학과)
  • 투고 : 2010.01.15
  • 심사 : 2010.02.22
  • 발행 : 2010.02.28

초록

Emerging of antibiotic resistance of pathogenic bacteria is now a very serious problem in the clinics to treat the diseases, which have been easy to cure by antibiotic treatments before. Unfortunately, antibiotics developed till now are not effective any more against the resistant bacteria. Lots of efforts to discover new antibiotics having novel and unique structures and functions are really urgent and undergoing in the whole world. In this study, we tried to screen and isolate Same unique bacterial strains producing antibacterial substances from the sea water, which is the poor environment for bacteria 10 make their growing. Three bacterial strains among 916 strains isolated showed inhibition clear zone on the marine agar plate growing pathogenic bacteria including Acinetobacter baumannii, Edwardsiella tarda, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella enterica. One of them, which was identified as Bacillus sp. DH-9 from 16S rRNA gene analysis, showed especially considerable antibacterial activity against S. aureus which is notorious for methicillin resistant S. aureus (MRSA). The growth of S. aureus was totally inhibited when the supernatant of Bacillus sp. DH-9 culture was treated on.

키워드

참고문헌

  1. Berns KI and Thomas CA. 1965. Isolation of the high molecular DNA from Haemophilus injluenzae. J Mol BioI 11, 476-490. https://doi.org/10.1016/S0022-2836(65)80004-3
  2. Butler MS and Buss AD. 2006. Natural products-the future scaffolds for novel antibiotics? Biochem Pharmacol 71, 930-940. https://doi.org/10.1016/j.bcp.2005.11.012
  3. Clinical and Laboratory Standards Institute (CLSI). 2009. Performance standards for antimicrobial disk susceptibility tests; Approved standard-10th ed. CLSI. Wayne, PA, U.S.A., M02-A10.
  4. Dunbar J, Ticknor LO and Kuske CR. 2000. Assessment of microbial diversity in four southwestern United States soils by 16S rRNA gene terminal restriction fragment analysis. Appl Environ Microbiol 66, 2943-2950. https://doi.org/10.1128/AEM.66.7.2943-2950.2000
  5. Fraise AP. 2006. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? J Infect 53, 293-300. https://doi.org/10.1016/j.jinf.2006.05.014
  6. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J and Martone WJ. 1996. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 275, 234-240. https://doi.org/10.1001/jama.275.3.234
  7. Gram L, Melchiorsen J and Bruhn JB. 2009. Antibacterial activity of marine culturable bacteria collected from a global sampling of ocean surface waters and surface swabs of marine organisms. Mar Biotechnol (NY) 2009 Oct 13. [Epub ahead of print].
  8. GuIder TA and Moore BS. 2009. Chasing the treasures of the sea-bacterial marine natural products. Curr Opin Microbiol 12, 252-260. https://doi.org/10.1016/j.mib.2009.05.002
  9. Isnansetyo A, Horikawa M and Kamei Y. 2001. In vitro anti-methicillin-resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga. J Antimicrob Chemother 47, 724-725. https://doi.org/10.1093/oxfordjournals.jac.a002694
  10. Kapil A. 2005. The challenge of antibiotic resistance: Need to comtemplate. Indian J Med Res 121, 83-91.
  11. Neu HC. 1992. The crisis in antibiotic resistance. Science 257, 1064-1073. https://doi.org/10.1126/science.257.5073.1064
  12. Normark BH and Normark S. 2002. Evolution and spread of antibiotic resistance. J Intern Med 252, 91-106. https://doi.org/10.1046/j.1365-2796.2002.01026.x
  13. Salomon CE, Magarvey NA and Sherman DH. 2004. Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery. Nat Prod Rep 21, 105-121. https://doi.org/10.1039/b301384g
  14. Stavri M, Piddock LJ and Gibbons S. 2007. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59, 1247-1260. https://doi.org/10.1093/jac/dkl460
  15. Willey JM, Sherwood LM and Woolverton CJ. 2008. Prescott, Harley, and Kleins's Microbiology 7th ed. McGraw-Hill Inc. New York, NY, U.S.A., 578-582.